Global Organ Transplant Immunosuppressant Market Growth 2022-2028
As the global economy mends, the 2021 growth of Organ Transplant Immunosuppressant will have significant change from previous year. According to our latest study, the global Organ Transplant Immunosuppressant market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Organ Transplant Immunosuppressant market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Organ Transplant Immunosuppressant market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Organ Transplant Immunosuppressant market, reaching US$ million by the year 2028. As for the Europe Organ Transplant Immunosuppressant landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Organ Transplant Immunosuppressant players cover Roche, Astellas Pharma Inc., Huadong Pharmaceutical, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Organ Transplant Immunosuppressant market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tacrolimus
Mycophenolate Mofetil
Cyclosporin
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Liver Transplant
Kidney Transplant
Heart Transplant
Other Organ Transplant
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
Astellas Pharma Inc.
Huadong Pharmaceutical
Novartis
Catalent Pharma
Cinkate Corporation
Cilag
Genzyme
Changzhou Pharm
North China Pharmaceutical Group Corporation
SL PHARM
Livzon Pharmaceutical Group Inc.,
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Organ Transplant Immunosuppressant Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Organ Transplant Immunosuppressant by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Organ Transplant Immunosuppressant by Country/Region, 2017, 2022 & 2028
2.2 Organ Transplant Immunosuppressant Segment by Type
2.2.1 Tacrolimus
2.2.2 Mycophenolate Mofetil
2.2.3 Cyclosporin
2.2.4 Others
2.3 Organ Transplant Immunosuppressant Sales by Type
2.3.1 Global Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2022)
2.3.2 Global Organ Transplant Immunosuppressant Revenue and Market Share by Type (2017-2022)
2.3.3 Global Organ Transplant Immunosuppressant Sale Price by Type (2017-2022)
2.4 Organ Transplant Immunosuppressant Segment by Application
2.4.1 Liver Transplant
2.4.2 Kidney Transplant
2.4.3 Heart Transplant
2.4.4 Other Organ Transplant
2.5 Organ Transplant Immunosuppressant Sales by Application
2.5.1 Global Organ Transplant Immunosuppressant Sale Market Share by Application (2017-2022)
2.5.2 Global Organ Transplant Immunosuppressant Revenue and Market Share by Application (2017-2022)
2.5.3 Global Organ Transplant Immunosuppressant Sale Price by Application (2017-2022)
3 Global Organ Transplant Immunosuppressant by Company
3.1 Global Organ Transplant Immunosuppressant Breakdown Data by Company
3.1.1 Global Organ Transplant Immunosuppressant Annual Sales by Company (2020-2022)
3.1.2 Global Organ Transplant Immunosuppressant Sales Market Share by Company (2020-2022)
3.2 Global Organ Transplant Immunosuppressant Annual Revenue by Company (2020-2022)
3.2.1 Global Organ Transplant Immunosuppressant Revenue by Company (2020-2022)
3.2.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Company (2020-2022)
3.3 Global Organ Transplant Immunosuppressant Sale Price by Company
3.4 Key Manufacturers Organ Transplant Immunosuppressant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Organ Transplant Immunosuppressant Product Location Distribution
3.4.2 Players Organ Transplant Immunosuppressant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Organ Transplant Immunosuppressant by Geographic Region
4.1 World Historic Organ Transplant Immunosuppressant Market Size by Geographic Region (2017-2022)
4.1.1 Global Organ Transplant Immunosuppressant Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Organ Transplant Immunosuppressant Annual Revenue by Geographic Region
4.2 World Historic Organ Transplant Immunosuppressant Market Size by Country/Region (2017-2022)
4.2.1 Global Organ Transplant Immunosuppressant Annual Sales by Country/Region (2017-2022)
4.2.2 Global Organ Transplant Immunosuppressant Annual Revenue by Country/Region
4.3 Americas Organ Transplant Immunosuppressant Sales Growth
4.4 APAC Organ Transplant Immunosuppressant Sales Growth
4.5 Europe Organ Transplant Immunosuppressant Sales Growth
4.6 Middle East & Africa Organ Transplant Immunosuppressant Sales Growth
5 Americas
5.1 Americas Organ Transplant Immunosuppressant Sales by Country
5.1.1 Americas Organ Transplant Immunosuppressant Sales by Country (2017-2022)
5.1.2 Americas Organ Transplant Immunosuppressant Revenue by Country (2017-2022)
5.2 Americas Organ Transplant Immunosuppressant Sales by Type
5.3 Americas Organ Transplant Immunosuppressant Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Organ Transplant Immunosuppressant Sales by Region
6.1.1 APAC Organ Transplant Immunosuppressant Sales by Region (2017-2022)
6.1.2 APAC Organ Transplant Immunosuppressant Revenue by Region (2017-2022)
6.2 APAC Organ Transplant Immunosuppressant Sales by Type
6.3 APAC Organ Transplant Immunosuppressant Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Organ Transplant Immunosuppressant by Country
7.1.1 Europe Organ Transplant Immunosuppressant Sales by Country (2017-2022)
7.1.2 Europe Organ Transplant Immunosuppressant Revenue by Country (2017-2022)
7.2 Europe Organ Transplant Immunosuppressant Sales by Type
7.3 Europe Organ Transplant Immunosuppressant Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Organ Transplant Immunosuppressant by Country
8.1.1 Middle East & Africa Organ Transplant Immunosuppressant Sales by Country (2017-2022)
8.1.2 Middle East & Africa Organ Transplant Immunosuppressant Revenue by Country (2017-2022)
8.2 Middle East & Africa Organ Transplant Immunosuppressant Sales by Type
8.3 Middle East & Africa Organ Transplant Immunosuppressant Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Organ Transplant Immunosuppressant
10.3 Manufacturing Process Analysis of Organ Transplant Immunosuppressant
10.4 Industry Chain Structure of Organ Transplant Immunosuppressant
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Organ Transplant Immunosuppressant Distributors
11.3 Organ Transplant Immunosuppressant Customer
12 World Forecast Review for Organ Transplant Immunosuppressant by Geographic Region
12.1 Global Organ Transplant Immunosuppressant Market Size Forecast by Region
12.1.1 Global Organ Transplant Immunosuppressant Forecast by Region (2023-2028)
12.1.2 Global Organ Transplant Immunosuppressant Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Organ Transplant Immunosuppressant Forecast by Type
12.7 Global Organ Transplant Immunosuppressant Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Organ Transplant Immunosuppressant Product Offered
13.1.3 Roche Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Astellas Pharma Inc.
13.2.1 Astellas Pharma Inc. Company Information
13.2.2 Astellas Pharma Inc. Organ Transplant Immunosuppressant Product Offered
13.2.3 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Astellas Pharma Inc. Main Business Overview
13.2.5 Astellas Pharma Inc. Latest Developments
13.3 Huadong Pharmaceutical
13.3.1 Huadong Pharmaceutical Company Information
13.3.2 Huadong Pharmaceutical Organ Transplant Immunosuppressant Product Offered
13.3.3 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Huadong Pharmaceutical Main Business Overview
13.3.5 Huadong Pharmaceutical Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Organ Transplant Immunosuppressant Product Offered
13.4.3 Novartis Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Catalent Pharma
13.5.1 Catalent Pharma Company Information
13.5.2 Catalent Pharma Organ Transplant Immunosuppressant Product Offered
13.5.3 Catalent Pharma Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Catalent Pharma Main Business Overview
13.5.5 Catalent Pharma Latest Developments
13.6 Cinkate Corporation
13.6.1 Cinkate Corporation Company Information
13.6.2 Cinkate Corporation Organ Transplant Immunosuppressant Product Offered
13.6.3 Cinkate Corporation Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Cinkate Corporation Main Business Overview
13.6.5 Cinkate Corporation Latest Developments
13.7 Cilag
13.7.1 Cilag Company Information
13.7.2 Cilag Organ Transplant Immunosuppressant Product Offered
13.7.3 Cilag Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Cilag Main Business Overview
13.7.5 Cilag Latest Developments
13.8 Genzyme
13.8.1 Genzyme Company Information
13.8.2 Genzyme Organ Transplant Immunosuppressant Product Offered
13.8.3 Genzyme Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Genzyme Main Business Overview
13.8.5 Genzyme Latest Developments
13.9 Changzhou Pharm
13.9.1 Changzhou Pharm Company Information
13.9.2 Changzhou Pharm Organ Transplant Immunosuppressant Product Offered
13.9.3 Changzhou Pharm Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Changzhou Pharm Main Business Overview
13.9.5 Changzhou Pharm Latest Developments
13.10 North China Pharmaceutical Group Corporation
13.10.1 North China Pharmaceutical Group Corporation Company Information
13.10.2 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product Offered
13.10.3 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 North China Pharmaceutical Group Corporation Main Business Overview
13.10.5 North China Pharmaceutical Group Corporation Latest Developments
13.11 SL PHARM
13.11.1 SL PHARM Company Information
13.11.2 SL PHARM Organ Transplant Immunosuppressant Product Offered
13.11.3 SL PHARM Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 SL PHARM Main Business Overview
13.11.5 SL PHARM Latest Developments
13.12 Livzon Pharmaceutical Group Inc.,
13.12.1 Livzon Pharmaceutical Group Inc., Company Information
13.12.2 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product Offered
13.12.3 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Livzon Pharmaceutical Group Inc., Main Business Overview
13.12.5 Livzon Pharmaceutical Group Inc., Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Organ Transplant Immunosuppressant Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Organ Transplant Immunosuppressant Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tacrolimus
Table 4. Major Players of Mycophenolate Mofetil
Table 5. Major Players of Cyclosporin
Table 6. Major Players of Others
Table 7. Global Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 8. Global Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2022)
Table 9. Global Organ Transplant Immunosuppressant Revenue by Type (2017-2022) & ($ million)
Table 10. Global Organ Transplant Immunosuppressant Revenue Market Share by Type (2017-2022)
Table 11. Global Organ Transplant Immunosuppressant Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 13. Global Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2022)
Table 14. Global Organ Transplant Immunosuppressant Revenue by Application (2017-2022)
Table 15. Global Organ Transplant Immunosuppressant Revenue Market Share by Application (2017-2022)
Table 16. Global Organ Transplant Immunosuppressant Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Organ Transplant Immunosuppressant Sales by Company (2020-2022) & (K Units)
Table 18. Global Organ Transplant Immunosuppressant Sales Market Share by Company (2020-2022)
Table 19. Global Organ Transplant Immunosuppressant Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Organ Transplant Immunosuppressant Revenue Market Share by Company (2020-2022)
Table 21. Global Organ Transplant Immunosuppressant Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Organ Transplant Immunosuppressant Producing Area Distribution and Sales Area
Table 23. Players Organ Transplant Immunosuppressant Products Offered
Table 24. Organ Transplant Immunosuppressant Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Organ Transplant Immunosuppressant Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Organ Transplant Immunosuppressant Sales Market Share Geographic Region (2017-2022)
Table 29. Global Organ Transplant Immunosuppressant Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Organ Transplant Immunosuppressant Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Organ Transplant Immunosuppressant Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Organ Transplant Immunosuppressant Sales Market Share by Country/Region (2017-2022)
Table 33. Global Organ Transplant Immunosuppressant Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Organ Transplant Immunosuppressant Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Organ Transplant Immunosuppressant Sales by Country (2017-2022) & (K Units)
Table 36. Americas Organ Transplant Immunosuppressant Sales Market Share by Country (2017-2022)
Table 37. Americas Organ Transplant Immunosuppressant Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Organ Transplant Immunosuppressant Revenue Market Share by Country (2017-2022)
Table 39. Americas Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 40. Americas Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2022)
Table 41. Americas Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 42. Americas Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2022)
Table 43. APAC Organ Transplant Immunosuppressant Sales by Region (2017-2022) & (K Units)
Table 44. APAC Organ Transplant Immunosuppressant Sales Market Share by Region (2017-2022)
Table 45. APAC Organ Transplant Immunosuppressant Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Organ Transplant Immunosuppressant Revenue Market Share by Region (2017-2022)
Table 47. APAC Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 48. APAC Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2022)
Table 49. APAC Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 50. APAC Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2022)
Table 51. Europe Organ Transplant Immunosuppressant Sales by Country (2017-2022) & (K Units)
Table 52. Europe Organ Transplant Immunosuppressant Sales Market Share by Country (2017-2022)
Table 53. Europe Organ Transplant Immunosuppressant Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Organ Transplant Immunosuppressant Revenue Market Share by Country (2017-2022)
Table 55. Europe Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 56. Europe Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2022)
Table 57. Europe Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 58. Europe Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Organ Transplant Immunosuppressant Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Organ Transplant Immunosuppressant Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Organ Transplant Immunosuppressant Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Organ Transplant Immunosuppressant Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Organ Transplant Immunosuppressant Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Organ Transplant Immunosuppressant Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Organ Transplant Immunosuppressant Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Organ Transplant Immunosuppressant
Table 68. Key Market Challenges & Risks of Organ Transplant Immunosuppressant
Table 69. Key Industry Trends of Organ Transplant Immunosuppressant
Table 70. Organ Transplant Immunosuppressant Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Organ Transplant Immunosuppressant Distributors List
Table 73. Organ Transplant Immunosuppressant Customer List
Table 74. Global Organ Transplant Immunosuppressant Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Organ Transplant Immunosuppressant Sales Market Forecast by Region
Table 76. Global Organ Transplant Immunosuppressant Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Organ Transplant Immunosuppressant Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Organ Transplant Immunosuppressant Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Organ Transplant Immunosuppressant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Organ Transplant Immunosuppressant Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Organ Transplant Immunosuppressant Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Organ Transplant Immunosuppressant Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Organ Transplant Immunosuppressant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Organ Transplant Immunosuppressant Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Organ Transplant Immunosuppressant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Organ Transplant Immunosuppressant Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Organ Transplant Immunosuppressant Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Organ Transplant Immunosuppressant Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Organ Transplant Immunosuppressant Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Organ Transplant Immunosuppressant Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Organ Transplant Immunosuppressant Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Organ Transplant Immunosuppressant Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Organ Transplant Immunosuppressant Revenue Market Share Forecast by Application (2023-2028)
Table 94. Roche Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 95. Roche Organ Transplant Immunosuppressant Product Offered
Table 96. Roche Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Roche Main Business
Table 98. Roche Latest Developments
Table 99. Astellas Pharma Inc. Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 100. Astellas Pharma Inc. Organ Transplant Immunosuppressant Product Offered
Table 101. Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Astellas Pharma Inc. Main Business
Table 103. Astellas Pharma Inc. Latest Developments
Table 104. Huadong Pharmaceutical Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 105. Huadong Pharmaceutical Organ Transplant Immunosuppressant Product Offered
Table 106. Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Huadong Pharmaceutical Main Business
Table 108. Huadong Pharmaceutical Latest Developments
Table 109. Novartis Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis Organ Transplant Immunosuppressant Product Offered
Table 111. Novartis Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Novartis Main Business
Table 113. Novartis Latest Developments
Table 114. Catalent Pharma Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 115. Catalent Pharma Organ Transplant Immunosuppressant Product Offered
Table 116. Catalent Pharma Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Catalent Pharma Main Business
Table 118. Catalent Pharma Latest Developments
Table 119. Cinkate Corporation Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 120. Cinkate Corporation Organ Transplant Immunosuppressant Product Offered
Table 121. Cinkate Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Cinkate Corporation Main Business
Table 123. Cinkate Corporation Latest Developments
Table 124. Cilag Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 125. Cilag Organ Transplant Immunosuppressant Product Offered
Table 126. Cilag Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Cilag Main Business
Table 128. Cilag Latest Developments
Table 129. Genzyme Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 130. Genzyme Organ Transplant Immunosuppressant Product Offered
Table 131. Genzyme Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Genzyme Main Business
Table 133. Genzyme Latest Developments
Table 134. Changzhou Pharm Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 135. Changzhou Pharm Organ Transplant Immunosuppressant Product Offered
Table 136. Changzhou Pharm Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Changzhou Pharm Main Business
Table 138. Changzhou Pharm Latest Developments
Table 139. North China Pharmaceutical Group Corporation Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 140. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product Offered
Table 141. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. North China Pharmaceutical Group Corporation Main Business
Table 143. North China Pharmaceutical Group Corporation Latest Developments
Table 144. SL PHARM Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 145. SL PHARM Organ Transplant Immunosuppressant Product Offered
Table 146. SL PHARM Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. SL PHARM Main Business
Table 148. SL PHARM Latest Developments
Table 149. Livzon Pharmaceutical Group Inc., Basic Information, Organ Transplant Immunosuppressant Manufacturing Base, Sales Area and Its Competitors
Table 150. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product Offered
Table 151. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Livzon Pharmaceutical Group Inc., Main Business
Table 153. Livzon Pharmaceutical Group Inc., Latest Developments
List of Figures
Figure 1. Picture of Organ Transplant Immunosuppressant
Figure 2. Organ Transplant Immunosuppressant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Organ Transplant Immunosuppressant Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Organ Transplant Immunosuppressant Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Organ Transplant Immunosuppressant Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tacrolimus
Figure 10. Product Picture of Mycophenolate Mofetil
Figure 11. Product Picture of Cyclosporin
Figure 12. Product Picture of Others
Figure 13. Global Organ Transplant Immunosuppressant Sales Market Share by Type in 2021
Figure 14. Global Organ Transplant Immunosuppressant Revenue Market Share by Type (2017-2022)
Figure 15. Organ Transplant Immunosuppressant Consumed in Liver Transplant
Figure 16. Global Organ Transplant Immunosuppressant Market: Liver Transplant (2017-2022) & (K Units)
Figure 17. Organ Transplant Immunosuppressant Consumed in Kidney Transplant
Figure 18. Global Organ Transplant Immunosuppressant Market: Kidney Transplant (2017-2022) & (K Units)
Figure 19. Organ Transplant Immunosuppressant Consumed in Heart Transplant
Figure 20. Global Organ Transplant Immunosuppressant Market: Heart Transplant (2017-2022) & (K Units)
Figure 21. Organ Transplant Immunosuppressant Consumed in Other Organ Transplant
Figure 22. Global Organ Transplant Immunosuppressant Market: Other Organ Transplant (2017-2022) & (K Units)
Figure 23. Global Organ Transplant Immunosuppressant Sales Market Share by Application (2017-2022)
Figure 24. Global Organ Transplant Immunosuppressant Revenue Market Share by Application in 2021
Figure 25. Organ Transplant Immunosuppressant Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Organ Transplant Immunosuppressant Revenue Market Share by Company in 2021
Figure 27. Global Organ Transplant Immunosuppressant Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Organ Transplant Immunosuppressant Revenue Market Share by Geographic Region in 2021
Figure 29. Global Organ Transplant Immunosuppressant Sales Market Share by Region (2017-2022)
Figure 30. Global Organ Transplant Immunosuppressant Revenue Market Share by Country/Region in 2021
Figure 31. Americas Organ Transplant Immunosuppressant Sales 2017-2022 (K Units)
Figure 32. Americas Organ Transplant Immunosuppressant Revenue 2017-2022 ($ Millions)
Figure 33. APAC Organ Transplant Immunosuppressant Sales 2017-2022 (K Units)
Figure 34. APAC Organ Transplant Immunosuppressant Revenue 2017-2022 ($ Millions)
Figure 35. Europe Organ Transplant Immunosuppressant Sales 2017-2022 (K Units)
Figure 36. Europe Organ Transplant Immunosuppressant Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Organ Transplant Immunosuppressant Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Organ Transplant Immunosuppressant Revenue 2017-2022 ($ Millions)
Figure 39. Americas Organ Transplant Immunosuppressant Sales Market Share by Country in 2021
Figure 40. Americas Organ Transplant Immunosuppressant Revenue Market Share by Country in 2021
Figure 41. United States Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Organ Transplant Immunosuppressant Sales Market Share by Region in 2021
Figure 46. APAC Organ Transplant Immunosuppressant Revenue Market Share by Regions in 2021
Figure 47. China Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Organ Transplant Immunosuppressant Sales Market Share by Country in 2021
Figure 54. Europe Organ Transplant Immunosuppressant Revenue Market Share by Country in 2021
Figure 55. Germany Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Organ Transplant Immunosuppressant Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Organ Transplant Immunosuppressant Revenue Market Share by Country in 2021
Figure 62. Egypt Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Organ Transplant Immunosuppressant Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Organ Transplant Immunosuppressant in 2021
Figure 68. Manufacturing Process Analysis of Organ Transplant Immunosuppressant
Figure 69. Industry Chain Structure of Organ Transplant Immunosuppressant
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
